Every day in France, 10,000 blood donations are required to treat patients. A need that is constantly increasing with an ageing population and with the rise of cancers and other diseases.
The French Blood Establishment (EFS) is the only civil operator of blood transfusions in France ensuring the country to be self-sufficient by fulfilling a public health mission. Its mission does not end here. The EFS is conducting innovative medical research, mostly in partnership with Inserm and universities. Its expertise in Hematology, Transfusion medicine, Cell & tissue therapy, Immunotherapy & Oncology and Infectious diseases & diagnostic is highly recognized.
The EFS has 66 patent families in these domains (2020), looking for licensing-out or industrial partnerships. The EFS is also a key player in the French bioproduction system with its 4 production platforms of advanced therapy medicinal products (ATMP) in Besançon, Nantes, Créteil and Grenoble for which it has the status of pharmaceutical establishment. Through its research and development / ATMP bioproduction activities, the EFS is at the heart of French healthtech.